Phase 2: Idarubicin Nanoparticle Formulation Development and Preclined Evaluation

  • Leggas, Markos (PI)
  • Mumper, Russell (CoI)
  • Wyse, Joseph (CoI)

Grants and Contracts Details

StatusFinished
Effective start/end date1/1/071/31/08